114 related articles for article (PubMed ID: 19513498)
1. Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome.
Holm R; Ali T; Svendsrud DH; Nesland JM; Kristensen GB; Lyng H
Oncol Rep; 2009 Jul; 22(1):11-5. PubMed ID: 19513498
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.
Wang Z; Tropè CG; Suo Z; Trøen G; Yang G; Nesland JM; Holm R
BMC Cancer; 2008 Oct; 8():308. PubMed ID: 18950492
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
4. Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue.
Simpson PT; Gale T; Reis-Filho JS; Jones C; Parry S; Steele D; Cossu A; Budroni M; Palmieri G; Lakhani SR
J Pathol; 2004 Mar; 202(3):274-85. PubMed ID: 14991892
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3sigma expression as a prognostic marker in undifferentiated nasopharyngeal carcinoma.
Chan SY; To KF; Leung SF; Yip WW; Mak MK; Chung GT; Lo KW
Oncol Rep; 2010 Oct; 24(4):949-55. PubMed ID: 20811675
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteomic analysis of beta-catenin-mediated malignant progression of esophageal squamous cell carcinoma.
Ren HZ; Wang JS; Pan GQ; Lv H; Wen JF; Luo GQ; Wang KS; Zhang PF
Dis Esophagus; 2010 Feb; 23(2):175-84. PubMed ID: 19664078
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
9. Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor.
Suzuki T; Urano T; Miki Y; Moriya T; Akahira J; Ishida T; Horie K; Inoue S; Sasano H
Cancer Sci; 2007 May; 98(5):644-51. PubMed ID: 17359284
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
11. Klotho expression in cervical cancer: differential expression in adenocarcinoma and squamous cell carcinoma.
Aviel-Ronen S; Rubinek T; Zadok O; Vituri A; Avivi C; Wolf I; Barshack I
J Clin Pathol; 2016 Jan; 69(1):53-7. PubMed ID: 26209729
[TBL] [Abstract][Full Text] [Related]
12. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
13. Loss of 14-3-3 sigma protein expression and presence of human papillomavirus type 16 E6 in oral squamous cell carcinoma.
Bhawal UK; Sugiyama M; Nomura Y; Kuniyasu H; Tsukinoki K
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1055-9. PubMed ID: 18936350
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of TRAIL signalling molecules in cervical squamous cell carcinoma.
Yao Q; Du J; Lin J; Luo Y; Wang Y; Liu Y; Zhang B; Ren C; Liu C
J Clin Pathol; 2016 Feb; 69(2):122-7. PubMed ID: 26254281
[TBL] [Abstract][Full Text] [Related]
15. Lgr5 is a potential prognostic marker in patients with cervical carcinoma.
Sun B; Ye X; Li Y; Zhang W
Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068
[TBL] [Abstract][Full Text] [Related]
16. Aberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignancies.
Motokura T; Nakamura Y; Sato H
BMC Cancer; 2007 Nov; 7():217. PubMed ID: 18036248
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation of the 14-3-3σ promoter leads to increased expression in non-small cell lung cancer.
Radhakrishnan VM; Jensen TJ; Cui H; Futscher BW; Martinez JD
Genes Chromosomes Cancer; 2011 Oct; 50(10):830-6. PubMed ID: 21755566
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling.
Liu Y; Chen Q; Zhang JT
J Proteome Res; 2004; 3(4):728-35. PubMed ID: 15359725
[TBL] [Abstract][Full Text] [Related]
19. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
20. Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.
Erben PB; Brunner K; Hecht M; Haderlein M; Büttner-Herold M; Agaimy A; Fietkau R; Hartmann A; Distel LV
Int J Clin Exp Pathol; 2015; 8(12):15814-24. PubMed ID: 26884852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]